Evaxion Biotech A/S (EVAX)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 4.2900 |
| Open | 4.1300 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 4.0700 - 4.1900 |
| 52-week range | 2.8240 - 18.5000 |
| Volume | |
| Avg. volume | 61,777 |
| Market cap | 21.747M |
| Beta (5Y monthly) | -0.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data
Evaxion (EVAX) gains 20% on positive results from the pre-clinical studies of its EVX-B1 vaccine candidate in large non-rodent animals, which is being developed to treat S. aureus infection.
- Insider Monkey
Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript
Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript April 2, 2024 Evaxion Biotech A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Christian Kanstrup: Hello, everyone, and a very warm welcome to this Evaxion Business Update Conference call on the […]
- Simply Wall St.
When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit?
With the business potentially at an important milestone, we thought we'd take a closer look at Evaxion Biotech A/S...
© 2024 Yahoo. All rights reserved.